Related Experiment Video
Updated: Aug 1, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Prevention of respiratory syncytial virus infection in high risk infants
Insights
Serious respiratory syncytial virus (RSV) illness in premature infants and those with chronic lung disease (CLD) can be reduced. Prophylaxis with Synagis is recommended for high-risk infants during the RSV season.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Respiratory Syncytial Virus (RSV) poses a significant threat to vulnerable infant populations.
- Premature infants and those with chronic lung disease (CLD) are at higher risk for severe RSV illness.
Purpose of the Study:
- To evaluate the effectiveness of Synagis prophylaxis in reducing serious RSV illness.
- To identify high-risk infant groups who may benefit from RSV prophylaxis.
Main Methods:
- Administration of Synagis at a dose of 15 mg/kg intramuscularly monthly during the RSV season.
- Ongoing clinical trials to assess Synagis use in infants with congenital heart disease (CHD) and cystic fibrosis.
Main Results:
- Synagis significantly reduces the incidence of serious RSV illness in premature infants and those with CLD.
- Prophylaxis with Synagis is considered prudent for infants with CHD and cystic fibrosis.
Conclusions:
- Synagis is a safe and effective option for preventing serious RSV illness in high-risk infants.
- Ease of administration makes Synagis the preferred choice for most high-risk children.
Abstract:
The incidence of serious RSV illness in premature infants and in infants with CLD can be reduced. Prophylaxis in infants with CHD and cystic fibrosis seem prudent as well, and clinical trials are currently under way to evaluate the use of Synagis in these high-risk groups. Synagis is preferred for most high-risk children because of its ease of administration, safety and effectiveness. The dose for Synagis is 15 mg/kg i.m. monthly during RSV season.
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Respiratory Syncytial Virus Disease

